Zymergen Inc. ZY
We take great care to ensure that the data presented and summarized in this overview for Zymergen Inc. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Latest Institutional Activity in ZY
Top Purchases
Top Sells
About ZY
Zymergen Inc. design, develop, and commercialize microbes, molecules, and materials. It offers an automation solution comprising reconfigurable automation carts, a modular hardware building blocks that allow for assembly of work cells customized for the particular needs of a lab; and automation control software, a cloud-based software used to control integrated automation systems. It serves electronics, packaging, healthcare, agriculture, and other industries. Zymergen Inc. was incorporated in 2013 and is based in Emeryville, California.
Insider Transactions at ZY
Insider Transaction List
View allDate | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Oct 19
2022
|
Svf Excaliber (Cayman) LTD > 10% Shareholder |
SELL
Other acquisition or disposition
|
Indirect |
26,614,219
-100.0%
|
-
|
Oct 19
2022
|
Enakshi Singh Chief Financial Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
462,241
-100.0%
|
-
|
Oct 19
2022
|
Zachariah Serber Director |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
80,000
-100.0%
|
-
|
Oct 19
2022
|
Zachariah Serber Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
2,551,685
-100.0%
|
-
|
Oct 19
2022
|
Sandra E Peterson Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
119,119
-100.0%
|
-
|
Oct 19
2022
|
Matthew Ocko Director |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
7,366,635
-100.0%
|
-
|
Oct 19
2022
|
Travis Murdoch Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
79,697
-100.0%
|
-
|
Oct 19
2022
|
Christine Marie Gorjanc Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
50,000
-100.0%
|
-
|
Oct 19
2022
|
Jay T Flatley Chairman and Acting CEO |
SELL
Sale (or disposition) back to the issuer
|
Direct |
144,789
-100.0%
|
-
|
Oct 19
2022
|
Steven Chu Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
50,000
-100.0%
|
-
|
Oct 03
2022
|
Enakshi Singh Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
3,786
-0.81%
|
$7,572
$2.8 P/Share
|
Sep 02
2022
|
Enakshi Singh Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
3,928
-0.84%
|
$7,856
$2.21 P/Share
|
Sep 02
2022
|
Zachariah Serber Director |
SELL
Open market or private sale
|
Direct |
3,268
-0.13%
|
$6,536
$2.21 P/Share
|
Sep 02
2022
|
Mina Kim Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
3,410
-1.13%
|
$6,820
$2.21 P/Share
|
Aug 30
2022
|
Enakshi Singh Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
15,365
-3.17%
|
$30,730
$2.27 P/Share
|
Aug 12
2022
|
Enakshi Singh Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
8,320
+1.69%
|
-
|
Aug 11
2022
|
Zachariah Serber Director |
SELL
Open market or private sale
|
Direct |
5,435
-0.21%
|
$16,305
$3.91 P/Share
|
Aug 02
2022
|
Zachariah Serber Director |
SELL
Open market or private sale
|
Direct |
2,966
-0.12%
|
$5,932
$2.61 P/Share
|
Aug 02
2022
|
Mina Kim Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
3,094
-1.01%
|
$6,188
$2.61 P/Share
|
Jul 05
2022
|
Zachariah Serber Director |
SELL
Open market or private sale
|
Direct |
2,797
-0.11%
|
$2,797
$1.32 P/Share
|